echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Japan passes bill to compensate people infected with hepatitis C in blood transfusions

    Japan passes bill to compensate people infected with hepatitis C in blood transfusions

    • Last Update: 2020-07-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Japan's Senate passed a bill on the 11th to compensatevictims of hepatitis C infection in blood transfusions in the 1970s and 1990sIn addition to financial compensation, the government must also apologize to the victimsThe bill had previously been unanimously passed in the House of Representatives"The government should acknowledge its responsibility for failing to stop the spread of the crisis,inflicting significant harm on patients," the text readsThe Government should sincerely apologize to the victims and their families"After the passage of thebill, Japanese Prime Minister Yasuo Fukuda issued a statement saying, "I sincerely apologize to the victims and their families."officials at Japan's Ministry of Health, Labour and Welfare said the victims would each receive compensation of 1
    2
    million yen
    (about109,000 yen) and40 million yen (
    about $365,000) depending on the severity of the condition The compensation will be jointly borne by the Government of Japan and companies such as the of Japan Pharmaceutical Co., Ltd and Mitsubishi Pharmaceutical Co., Ltd of In the 1970s and early 1990s
    contaminated blood products were used for surgery or childbirth in Japan, causing thousands of people to develop hepatitis C Hepatitis C is a viral liver disease , mainly through blood transmission, can develop into chronic hepatitis
    , cirrhosis and liver cancer have filed a lawsuit about 2
    00 victims , accusing the government of poor lying allowing substandard blood products into hospitals The lawsuit lasted five years , with victims claiming a total of about 9
    .8 billion yen (about $83 million ) There are five courts in Japan that hear the case Courts in Tokyo , Osaka and Fukuoka, , have found the to be held responsible the government and pharmaceutical companies But prosecutors last year rejected an out-of-court settlement on the grounds that the government had not admitted responsibility After the compensation decree was issued, , a hepatitis C patient who represents the prosecution, said: "The five-year campaign has finally paid off "
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.